IMMUNOHISTOCHEMISTRY GATA-3 Test is a medical test that is used to diagnose symptoms related to breast cancer, urinary bladder cancer, and other cancers. DNA Labs India offers this test at a cost of INR 3500.
Symptoms of Breast Cancer and Urinary Bladder Cancer
Breast cancer is one of the most common cancers in women. The symptoms of breast cancer may include:
- Lump or thickening in the breast or underarm area
- Change in the size or shape of the breast
- Dimpling or puckering of the skin
- Nipple discharge or inversion
- Redness or scaliness of the nipple or breast skin
Urinary bladder cancer is a type of cancer that starts in the bladder. The symptoms of urinary bladder cancer may include:
- Blood in the urine
- Frequent urination
- Painful urination
- Lower back pain
- Loss of appetite and weight loss
Diagnosis of Breast Cancer, Urinary Bladder Cancer, and Other Cancers
IMMUNOHISTOCHEMISTRY GATA-3 Test is a medical test that is used to diagnose symptoms related to breast cancer, urinary bladder cancer, and other cancers. This test is based on the detection of GATA-3 protein expression in cancer cells.
The IMMUNOHISTOCHEMISTRY GATA-3 Test is a simple and non-invasive test that can be performed on a tissue sample from the affected area. The tissue sample is then examined under a microscope to determine the presence of GATA-3 protein expression.
Cost of IMMUNOHISTOCHEMISTRY GATA-3 Test
The cost of IMMUNOHISTOCHEMISTRY GATA-3 Test at DNA Labs India is INR 3500. The test is done by highly skilled and experienced professionals using the latest technology and equipment to ensure accurate results.
Conclusion
IMMUNOHISTOCHEMISTRY GATA-3 Test is an important medical test that can help in the diagnosis of various types of cancers, including breast cancer, urinary bladder cancer, and others. DNA Labs India offers this test at an affordable cost of INR 3500. If you are experiencing any of the symptoms related to these cancers, it is highly recommended to consult a doctor and get tested.
GATA-3 is useful in the diagnosis of Mammary and Urothelial carcinoma.